MEDICALLY REVIEWED

New Study Finds Semaglutide Associated with Increased Risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Semaglutide ozempic
A recent publication in JAMA Ophthalmology has brought to light potential risks associated with the use of semaglutide, a medication often prescribed for managing type 2 diabetes (T2D) and obesity.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

typhoid philippines
Senator Bong Go Concerned About Surging Typhoid Cases in the Philippines

Senator Christopher “Bong” Go, chairperson of the Senate Committee on Health and Demography, has expressed deep concern over the alarming increase in typhoid cases across the Philippines. With the Department of Health (DOH) reporting 17,531 cases this year, a 38% increase compared to the same period last year, Senator Go is urging Filipinos to prioritise their health through heightened vigilance, proper hygiene, and timely medical consultation.

Read More »
Thailand Covid-19
Promising Thai mRNA COVID-19 Vaccine With Longer Fridge Storage Advancing to Next Trial Phase

A new mRNA COVID-19 vaccine, ChulaCov19, developed in Thailand, has shown promise in Phase I trials for its durability and ability to be stored at fridge temperatures for up to three months. The development of a potentially more effective and locally-grown vaccine could have significant implications for vaccine distribution in low- and middle-income countries in the region, where storage and transport can be challenging.

Read More »

Have a health question?

Share it with us and get it answered by a doctor!